Se connecter
Recherche
Intranet
Thème

Biographie pas encore disponible.

Publications

2022
Kovachka S, Malloci G, Simsir M, Ruggerone P, Azoulay S, Mus-Veteau I, Inhibition of the drug efflux activity of Ptch1 as a promising strategy to overcome chemotherapy resistance in cancer cells., Eur J Med Chem 2022 Jun; 236(): 114306.
2022
Feliz Morel ÁJ, Hasanovic A, Morin A, Prunier C, Magnone V, Lebrigand K, Aouad A, Cogoluegnes S, Favier J, Pasquier C, Mus-Veteau I, Persistent Properties of a Subpopulation of Cancer Cells Overexpressing the Hedgehog Receptor Patched., Pharmaceutics 2022 May; 14(5): .
2022
Braud V, Cazals F, Duca M, Mus-Veteau I, Pasquier C, Soriani O, [Highlights of the UCAncer 2021 symposium on multidisciplinary approaches to cancer research]., Bull Cancer 2022 Apr; 109(4): 505-509.
2022
Kovachka S, Soule P, Mus-Veteau I, Microscale Thermophoresis to Evaluate the Functionality of Heterologously Overexpressed Membrane Proteins in Membrane Preparations., Methods Mol Biol 2022 ; 2507(): 445-461.
2021
Kovachka S, Malloci G, Vargiu AV, Azoulay S, Mus-Veteau I, Ruggerone P, Molecular insights into the Patched1 drug efflux inhibitory activity of panicein A hydroquinone: a computational study., Phys Chem Chem Phys 2021 Apr; 23(13): 8013-8022.
2021
Durand N, Simsir M, Signetti L, Labbal F, Ballotti R, Mus-Veteau I, Methiothepin Increases Chemotherapy Efficacy against Resistant Melanoma Cells., Molecules 2021 Mar; 26(7): .
2021
Simsir M, Broutin I, Mus-Veteau I, Cazals F, Studying dynamics without explicit dynamics: A structure-based study of the export mechanism by AcrB., Proteins 2021 Mar; 89(3): 259-275.
2021
Macia E, Vazquez-Rojas M, Robiolo A, Fayad R, Abélanet S, Mus-Veteau I, Fontaine-Vive F, Mehiri M, Luton F, Franco M, Chlortetracycline, a Novel Arf Inhibitor That Decreases the Arf6-Dependent Invasive Properties of Breast Cancer Cells., Molecules 2021 Feb; 26(4): .
2020
Hasanovic A, Simsir M, Choveau FS, Lalli E, Mus-Veteau I, Astemizole Sensitizes Adrenocortical Carcinoma Cells to Doxorubicin by Inhibiting Patched Drug Efflux Activity., Biomedicines 2020 Jul; 8(8): .
2020
Signetti L, Elizarov N, Simsir M, Paquet A, Douguet D, Labbal F, Debayle D, Di Giorgio A, Biou V, Girard C, Duca M, Bretillon L, Bertolotto C, Verrier B, Azoulay S, Mus-Veteau I, Inhibition of Patched Drug Efflux Increases Vemurafenib Effectiveness against Resistant BrafV600E Melanoma., Cancers (Basel) 2020 Jun; 12(6): .
2018
Hasanovic A, Mus-Veteau I, Targeting the Multidrug Transporter Ptch1 Potentiates Chemotherapy Efficiency., Cells 2018 Aug; 7(8): .
2018
Hasanovic A, Ruggiero C, Jung S, Rapa I, Signetti L, Ben Hadj M, Terzolo M, Beuschlein F, Volante M, Hantel C, Lalli E, Mus-Veteau I, Targeting the multidrug transporter Patched potentiates chemotherapy efficiency on adrenocortical carcinoma in vitro and in vivo., Int J Cancer 2018 Jul; 143(1): 199-211.
2016
Fiorini L, Mus-Veteau I, Method to Screen Multidrug Transport Inhibitors Using Yeast Overexpressing a Human MDR Transporter., Methods Mol Biol 2016 ; 1432(): 303-18.
2015
Fiorini L, Tribalat MA, Sauvard L, Cazareth J, Lalli E, Broutin I, Thomas OP, Mus-Veteau I, Natural paniceins from mediterranean sponge inhibit the multidrug resistance activity of Patched and increase chemotherapy efficiency on melanoma cells., Oncotarget 2015 Sep; 6(26): 22282-97.
2015
Figeac F, Dagouassat M, Mahrouf-Yorgov M, Le Gouvello S, Trébeau C, Sayed A, Stern JB, Validire P, Dubois-Randé JL, Boczkowski J, Mus-Veteau I, Rodriguez AM, Lung fibroblasts share mesenchymal stem cell features which are altered in chronic obstructive pulmonary disease via the overactivation of the Hedgehog signaling pathway., PLoS One 2015 ; 10(3): e0121579.
2014
Mus-Veteau I, Lambeau G, Special issue: from membranes to pathologies., Biochimie 2014 Dec; 107 Pt A(): 1-2.
2013
Lalli E, Doghman M, Latre de Late P, El Wakil A, Mus-Veteau I, Beyond steroidogenesis: novel target genes for SF-1 discovered by genomics., Mol Cell Endocrinol 2013 May; 371(1-2): 154-9.
2012
Bidet M, Tomico A, Martin P, Guizouarn H, Mollat P, Mus-Veteau I, The Hedgehog receptor patched functions in multidrug transport and chemotherapy resistance., Mol Cancer Res 2012 Nov; 10(11): 1496-508.
2011
Bidet M, Joubert O, Lacombe B, Ciantar M, Nehmé R, Mollat P, Brétillon L, Faure H, Bittman R, Ruat M, Mus-Veteau I, The hedgehog receptor patched is involved in cholesterol transport., PLoS One 2011 ; 6(9): e23834.
2011
Hovers J, Potschies M, Polidori A, Pucci B, Raynal S, Bonneté F, Serrano-Vega MJ, Tate CG, Picot D, Pierre Y, Popot JL, Nehmé R, Bidet M, Mus-Veteau I, Busskamp H, Jung KH, Marx A, Timmins PA, Welte W, A class of mild surfactants that keep integral membrane proteins water-soluble for functional studies and crystallization., Mol Membr Biol 2011 Apr; 28(3): 171-81.
2010
Nehmé R, Mus-Veteau I, Proteins of the Hedgehog signaling pathway as therapeutic targets against cancer., Expert Rev Proteomics 2010 Aug; 7(4): 601-12.
2010
Nehmé R, Joubert O, Bidet M, Lacombe B, Polidori A, Pucci B, Mus-Veteau I, Stability study of the human G-protein coupled receptor, Smoothened., Biochim Biophys Acta 2010 Jun; 1798(6): 1100-10.
2010
Mus-Veteau I, Heterologous expression of membrane proteins for structural analysis., Methods Mol Biol 2010 ; 601(): 1-16.
2010
Joubert O, Nehmé R, Bidet M, Mus-Veteau I, Heterologous expression of human membrane receptors in the yeast Saccharomyces cerevisiae., Methods Mol Biol 2010 ; 601(): 87-103.
2009
Joubert O, Nehmé R, Fleury D, De Rivoyre M, Bidet M, Polidori A, Ruat M, Pucci B, Mollat P, Mus-Veteau I, Functional studies of membrane-bound and purified human Hedgehog receptor Patched expressed in yeast., Biochim Biophys Acta 2009 Sep; 1788(9): 1813-21.
2006
De Rivoyre M, Ruel L, Varjosalo M, Loubat A, Bidet M, Thérond P, Mus-Veteau I, Human receptors patched and smoothened partially transduce hedgehog signal when expressed in Drosophila cells., J Biol Chem 2006 Sep; 281(39): 28584-95.
2005
Pisani DF, Rivoyre MD, Ruel L, Bonino F, Bidet M, Dechesne CA, Mus-Veteau I, Mouse myodulin, a new potential angiogenic factor, functionally expressed in yeast., Biochem Biophys Res Commun 2005 Jun; 331(2): 552-6.
2005
De Rivoyre M, Bonino F, Ruel L, Bidet M, Thérond P, Mus-Veteau I, Human receptor Smoothened, a mediator of Hedgehog signalling, expressed in its native conformation in yeast., FEBS Lett 2005 Feb; 579(6): 1529-33.
2002
Mus-Veteau I, Heterologous expression and purification systems for structural proteomics of mammalian membrane proteins., Comp Funct Genomics 2002 ; 3(6): 511-7.
2000
Dave N, Troullier A, Mus-Veteau I, Duñach M, Leblanc G, Padrós E, Secondary structure components and properties of the melibiose permease from Escherichia coli: a fourier transform infrared spectroscopy analysis., Biophys J 2000 Aug; 79(2): 747-55.
2000
Cordat E, Leblanc G, Mus-Veteau I, Evidence for a role of helix IV in connecting cation- and sugar-binding sites of Escherichia coli melibiose permease., Biochemistry 2000 Apr; 39(15): 4493-9.
1998
Cordat E, Mus-Veteau I, Leblanc G, Structural studies of the melibiose permease of Escherichia coli by fluorescence resonance energy transfer. II. Identification of the tryptophan residues acting as energy donors., J Biol Chem 1998 Dec; 273(50): 33198-202.
1998
Maehrel C, Cordat E, Mus-Veteau I, Leblanc G, Structural studies of the melibiose permease of Escherichia coli by fluorescence resonance energy transfer. I. Evidence for ion-induced conformational change., J Biol Chem 1998 Dec; 273(50): 33192-7.
1996
Mus-Veteau I, Leblanc G, Melibiose permease of Escherichia coli: structural organization of cosubstrate binding sites as deduced from tryptophan fluorescence analyses., Biochemistry 1996 Sep; 35(37): 12053-60.
1996
Poolman B, Knol J, van der Does C, Henderson PJ, Liang WJ, Leblanc G, Pourcher T, Mus-Veteau I, Cation and sugar selectivity determinants in a novel family of transport proteins., Mol Microbiol 1996 Mar; 19(5): 911-22.
1995
Mus-Veteau I, Pourcher T, Leblanc G, Melibiose permease of Escherichia coli: substrate-induced conformational changes monitored by tryptophan fluorescence spectroscopy., Biochemistry 1995 May; 34(20): 6775-83.
1994
Mus-Veteau I, Guerlesquin F, Involvement of histidine residues in the catalytic mechanism of hydrogenases., Biochem Biophys Res Commun 1994 May; 201(1): 128-34.
1992
Mus-Veteau I, Dolla A, Guerlesquin F, Payan F, Czjzek M, Haser R, Bianco P, Haladjian J, Rapp-Giles BJ, Wall JD, Site-directed mutagenesis of tetraheme cytochrome c3. Modification of oxidoreduction potentials after heme axial ligand replacement., J Biol Chem 1992 Aug; 267(24): 16851-8.